Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pawinski

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1991
Risk-related adjuvant chemotherapy for stage I non-seminoma of the testisG Madej, A Pawinski
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 19, 2009
Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?C Nieder, A Pawinski, M Molls
American Journal of Public Health|June 1, 2006
Multisectoral responses to HIV/AIDS: applying research to policy and practiceRobert A Pawinski, Umesh G Lalloo
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 15, 2006
Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-NatalN Deghaye, R A Pawinski, C Desmond
Seminars in Oncology|October 1, 1994
A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesisG Madej, M Krzakowski, A Pawinski, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 8, 2014
Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvementC Nieder, K Marienhagen, A Dalhaug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative GroupJ B Vermorken, A Kobierska, B Chevallier, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 1998
PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative GroupA Pawinski, G Favalli, E Ploch, et al.
Pharmacy World & Science : PWS|February 11, 1999
Angiogenesis: possibilities for therapeutic interventionsW Wynendaele, A T van Oosterom, A Pawinski, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 6, 1999
Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative GroupA Pawinski, S Tumolo, G Hoesel, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1991
Risk-related adjuvant chemotherapy for stage I non-seminoma of the testisG Madej, A Pawinski
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 19, 2009
Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?C Nieder, A Pawinski, M Molls
American Journal of Public Health|June 1, 2006
Multisectoral responses to HIV/AIDS: applying research to policy and practiceRobert A Pawinski, Umesh G Lalloo
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 15, 2006
Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-NatalN Deghaye, R A Pawinski, C Desmond
Seminars in Oncology|October 1, 1994
A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesisG Madej, M Krzakowski, A Pawinski, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 8, 2014
Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvementC Nieder, K Marienhagen, A Dalhaug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative GroupJ B Vermorken, A Kobierska, B Chevallier, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 1998
PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative GroupA Pawinski, G Favalli, E Ploch, et al.
Pharmacy World & Science : PWS|February 11, 1999
Angiogenesis: possibilities for therapeutic interventionsW Wynendaele, A T van Oosterom, A Pawinski, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 6, 1999
Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative GroupA Pawinski, S Tumolo, G Hoesel, et al.
Pageof 2